New Approaches to Controlling Blood Pressure in the ICU
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
10/23/2018: 12:00 AM
Ends On:
6/30/2019: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Professor, Pharmacy Practice
Division of Specialty Care Pharmacy
Clinical Pharmacy Specialist, MICU
Barnes Jewish Hospital
Disclosures
Speaker's Bureau/Honoraria: La Jolla Pharmaceuticals
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 19th Annual St. Louis Critical Care Update, September 15, 2018, which was supported in part by The Foundation for Barnes-Jewish Hospital and CSL Behring LLC.
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine in St. Louis
Director, Medical Critical Care, Barnes-Jewish Hospital
Financial Relationships:
Speaker's Bureau/Honoraria: Allergan, Inc., Actavis, The Medicines Company,
Consulting/Advisory Committees: Merck & Company, Inc., Accelerate, Allergan, Inc., Arsanis, Paratek Pharmaceuticals, Inc, Paraxel
Paul Juang, PharmD, BCPS
Financial Relationships:
Speaker's Bureau/Honoraria: La Jolla Pharmaceuticals
Donna Prentice, RN, AMSN(R), ACNS-BC
Clinical Nurse Specialist
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Peggy Reed-Watts, MS, RRT
Manager, Respiratory Care Services
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Faculty
Paul Juang, PharmD, BCPSProfessor, Pharmacy Practice
Division of Specialty Care Pharmacy
Clinical Pharmacy Specialist, MICU
Barnes Jewish Hospital
Disclosures
Speaker's Bureau/Honoraria: La Jolla Pharmaceuticals
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 19th Annual St. Louis Critical Care Update, September 15, 2018, which was supported in part by The Foundation for Barnes-Jewish Hospital and CSL Behring LLC.
Planning Committee
Marin H. Kollef, MDProfessor of Medicine
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine in St. Louis
Director, Medical Critical Care, Barnes-Jewish Hospital
Financial Relationships:
Speaker's Bureau/Honoraria: Allergan, Inc., Actavis, The Medicines Company,
Consulting/Advisory Committees: Merck & Company, Inc., Accelerate, Allergan, Inc., Arsanis, Paratek Pharmaceuticals, Inc, Paraxel
Paul Juang, PharmD, BCPS
Financial Relationships:
Speaker's Bureau/Honoraria: La Jolla Pharmaceuticals
Donna Prentice, RN, AMSN(R), ACNS-BC
Clinical Nurse Specialist
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Peggy Reed-Watts, MS, RRT
Manager, Respiratory Care Services
Barnes Jewish Hospital, St Louis, MO
Financial Relationships: Speaker has nothing to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Recognize the available literature regarding the use of existing vasopressors
- Discuss the new literature regarding the use of new novel vasopressors
- Review the available evidence regarding use of BP lowering agents
Additional Information:
Target Audience: This course is designed by and for critical care specialists, pulmonologists, general surgeons, anesthesiologists, hospitalists, internists, family practice and emergency medicine physicians, as well as, pharmacists, physician assistants, nurse practitioners, and nurses in these fields.
Publication Date: October 23, 2018
Expiration Date: June 30, 2019
Target Audience: This course is designed by and for critical care specialists, pulmonologists, general surgeons, anesthesiologists, hospitalists, internists, family practice and emergency medicine physicians, as well as, pharmacists, physician assistants, nurse practitioners, and nurses in these fields.
Publication Date: October 23, 2018
Expiration Date: June 30, 2019
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
- Rhodes A. Crit. Care Med. 2017; 43:304.
- De Backer D. N. Engl. J. Med. 2010; 362:779.
- Schmittinger CA. Intensive. Care Med. 2012; 38:950.
- Sviri S. Crit. Care. 2014; 29:157.
- Russell JA. N. Engl. J. Med. 2008; 358:877.
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
